The effectiveness of ET depends on functional ER expression in ER-positive breast cancer lesions, and categorizing patients on the basis of functional status of ER may allow for prediction of response when assessing appropriate treatment strategies (10). This evidence concerns the gene ESR1 and breast carcinoma.